High immunogenicity and good tolerability of a new hepatitis A vaccine candidate

By Langer B.C.A.   Lovestad A.   Frosner G.G.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1089-1091

Elsevier

Access to resources Recommend Favorite

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children

By Castillo de Febres O.   Chacon de Petrola M.   Casanova de Escalona L.   Naveda O.   Naveda M.   Estopinan M.   Bordones G.   Zambrano B.   Garcia A.   Dumas R.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 656-664

Elsevier

Access to resources Recommend Favorite

Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children

By Duval B.   Boulianne N.   De Serres G.   Laflamme N.   De Wals P.   Masse R.   Trudeau G.   Delage G.   Desjardins L.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1467-1472

Elsevier

Access to resources Recommend Favorite

Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults

By Garin D.   Vidor E.   Wallon M.   Fanget B.   Brasseur P.   Delolme H.   Caron F.   Mojon M.   Gravey A.   Humbert G.   Flehmig B.   Peyron F.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

By Ambrosch F.   Wiedermann G.   Jonas S.   Althaust B.   Finkel B.   Gluck R.   Herzog C.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1209-1213

Elsevier

Access to resources Recommend Favorite